NO20014326D0 - Intranasal avlevering av pneumokokkpolysakkaridvaksiner - Google Patents
Intranasal avlevering av pneumokokkpolysakkaridvaksinerInfo
- Publication number
- NO20014326D0 NO20014326D0 NO20014326A NO20014326A NO20014326D0 NO 20014326 D0 NO20014326 D0 NO 20014326D0 NO 20014326 A NO20014326 A NO 20014326A NO 20014326 A NO20014326 A NO 20014326A NO 20014326 D0 NO20014326 D0 NO 20014326D0
- Authority
- NO
- Norway
- Prior art keywords
- intranasal delivery
- pneumococcal polysaccharide
- polysaccharide vaccines
- vaccines
- pneumococcal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99104803A EP1034792A1 (en) | 1999-03-11 | 1999-03-11 | Intranasal delivery of pneumococcal polysaccharide vaccines |
| PCT/EP2000/002749 WO2000053221A1 (en) | 1999-03-11 | 2000-03-10 | Intranasal delivery of pneumococcal polysaccharide vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014326D0 true NO20014326D0 (no) | 2001-09-05 |
| NO20014326L NO20014326L (no) | 2001-11-02 |
Family
ID=8237738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014326A NO20014326L (no) | 1999-03-11 | 2001-09-05 | Intranasal avlevering av pneumokokkpolysakkaridvaksiner |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20020094338A1 (no) |
| EP (2) | EP1034792A1 (no) |
| JP (1) | JP2003527309A (no) |
| AU (1) | AU779698B2 (no) |
| CA (1) | CA2364442A1 (no) |
| HU (1) | HUP0200405A2 (no) |
| NO (1) | NO20014326L (no) |
| NZ (1) | NZ514089A (no) |
| WO (1) | WO2000053221A1 (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
| GB0022742D0 (en) * | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| EP1404368B1 (en) * | 2001-06-07 | 2009-12-09 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| EP1423430A1 (en) * | 2001-08-16 | 2004-06-02 | Lyfjathroun H.F., Biopharmaceuticals | A method of producing antibodies ex-vivo |
| CN1642576A (zh) * | 2002-02-25 | 2005-07-20 | 药物发展有限公司 | 吸收增强剂 |
| NZ537120A (en) * | 2002-05-31 | 2008-07-31 | Univ Jefferson | Compositions and methods for transepithelial molecular transport |
| DK1549338T3 (da) | 2002-10-11 | 2011-03-28 | Novartis Vaccines & Diagnostic | Polypeptidvacciner til bred beskyttelse mod hypervirulente meningokok-afstamningslinier |
| CN1787839B (zh) | 2003-03-07 | 2011-09-28 | 惠氏控股公司 | 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物 |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| CA2560334A1 (en) | 2004-04-07 | 2005-10-20 | Axiogenesis Ag | Non-invasive, in vitro functional tissue assay systems |
| GB0502095D0 (en) | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
| EP2425854A1 (en) | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7709001B2 (en) * | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| GB0607088D0 (en) * | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| EP1973564B1 (en) | 2005-12-22 | 2016-11-09 | GlaxoSmithKline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| EP2493510B1 (en) | 2009-09-30 | 2020-07-08 | GlaxoSmithKline Biologicals SA | Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides |
| GB201101665D0 (en) | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
| WO2012085668A2 (en) | 2010-12-24 | 2012-06-28 | Novartis Ag | Compounds |
| TR201909110T4 (tr) | 2011-09-14 | 2019-07-22 | Glaxosmithkline Biologicals Sa | Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler. |
| KR20150021933A (ko) | 2012-05-22 | 2015-03-03 | 노파르티스 아게 | 수막염구균 혈청군 x 포합체 |
| US9855324B2 (en) | 2012-10-03 | 2018-01-02 | Glaxosmithkline Biologicals Sa | Immunogenic compositions |
| NZ755769A (en) * | 2014-01-21 | 2023-06-30 | Pfizer | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| EP3439704A1 (en) | 2016-04-05 | 2019-02-13 | GSK Vaccines S.r.l. | Immunogenic compositions |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| JP7132954B2 (ja) | 2017-06-10 | 2022-09-07 | インベントプライズ リミテッド ライアビリティ カンパニー | 改善された免疫原性及び結合活性を提供する２価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| AR117191A1 (es) | 2018-11-06 | 2021-07-21 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas |
| CA3191005A1 (en) | 2020-08-10 | 2022-02-17 | Inventprise, Inc. | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE128628T1 (de) * | 1990-08-13 | 1995-10-15 | American Cyanamid Co | Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff. |
| DK17093D0 (da) * | 1993-02-15 | 1993-02-15 | Lyfjathroun H F | Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder |
| US5955089A (en) * | 1993-04-20 | 1999-09-21 | Uab Research Foundation | Strain selection of pneumococcal surface proteins |
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
-
1999
- 1999-03-11 EP EP99104803A patent/EP1034792A1/en not_active Withdrawn
-
2000
- 2000-03-10 CA CA002364442A patent/CA2364442A1/en not_active Abandoned
- 2000-03-10 WO PCT/EP2000/002749 patent/WO2000053221A1/en not_active Application Discontinuation
- 2000-03-10 HU HU0200405A patent/HUP0200405A2/hu unknown
- 2000-03-10 JP JP2000603710A patent/JP2003527309A/ja not_active Withdrawn
- 2000-03-10 AU AU41130/00A patent/AU779698B2/en not_active Ceased
- 2000-03-10 NZ NZ514089A patent/NZ514089A/en unknown
- 2000-03-10 EP EP00920613A patent/EP1161259A1/en not_active Withdrawn
-
2001
- 2001-09-05 NO NO20014326A patent/NO20014326L/no not_active Application Discontinuation
- 2001-09-10 US US09/950,146 patent/US20020094338A1/en not_active Abandoned
-
2006
- 2006-02-21 US US11/358,021 patent/US20060140981A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020094338A1 (en) | 2002-07-18 |
| NZ514089A (en) | 2001-09-28 |
| JP2003527309A (ja) | 2003-09-16 |
| AU4113000A (en) | 2000-09-28 |
| HUP0200405A2 (en) | 2002-06-29 |
| EP1034792A1 (en) | 2000-09-13 |
| EP1161259A1 (en) | 2001-12-12 |
| NO20014326L (no) | 2001-11-02 |
| CA2364442A1 (en) | 2000-09-14 |
| AU779698B2 (en) | 2005-02-10 |
| US20060140981A1 (en) | 2006-06-29 |
| WO2000053221A1 (en) | 2000-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014326L (no) | Intranasal avlevering av pneumokokkpolysakkaridvaksiner | |
| ATE459373T1 (de) | Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae | |
| DE60014371D1 (de) | Polysaccharidderivat | |
| CY2011008I2 (el) | Εμβολιο γριπης | |
| FI20012462A (fi) | Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia | |
| DK1210113T3 (da) | Kombinerede vaccinepræparater | |
| DE60124632D1 (de) | Kreiselgebläse | |
| DE69930722D1 (de) | Luftmassagevorrichtung | |
| MA25489A1 (fr) | Vaccins | |
| DE60002650D1 (de) | Öladjuvierter Impfstoff | |
| NO20033737L (no) | PEG-konjugater av HGT-NK4 | |
| AU6600300A (en) | Pneumococcal vaccines | |
| DE60026979D1 (de) | Luftreiniger | |
| DE60117753D1 (de) | Raupenband kaoutchouk | |
| IS6381A (is) | Nýjung við notkun mótefna í bóluefni | |
| NO20023697D0 (no) | Cykliske heksapeptidderivater | |
| EP1189632A4 (en) | VACCINE FROM A COMBINATION OF PNEUMOCOCCAL SURFACE PROTEINS | |
| DE50008049D1 (de) | Schaufelradausleger | |
| FI20000400A (fi) | Viestinvälitysjärjestelmä ja vaate | |
| NO20022446L (no) | Etere av O-desmetyl-venlafaxine | |
| NO20032370L (no) | Polysakkaridforbindelse med immunstimulerende aktivitet | |
| DE50001130D1 (de) | Hochdruckreinigungsgerät | |
| DK1343826T3 (da) | Polysaccharid med immunstimulerende aktivitet | |
| FR2816188B1 (fr) | Cintre extensible | |
| FI4197U1 (fi) | Puhalluslaite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |